Cardinal Health, Inc. (NYSE:CAH) Shares Acquired by Greenleaf Trust

Greenleaf Trust increased its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 9.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,125 shares of the company’s stock after buying an additional 432 shares during the period. Greenleaf Trust’s holdings in Cardinal Health were worth $517,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Cornerstone Planning Group LLC purchased a new stake in shares of Cardinal Health during the third quarter worth approximately $26,000. BKM Wealth Management LLC purchased a new stake in shares of Cardinal Health during the fourth quarter worth approximately $30,000. Headlands Technologies LLC purchased a new stake in shares of Cardinal Health during the third quarter worth approximately $47,000. McGlone Suttner Wealth Management Inc. purchased a new stake in shares of Cardinal Health during the fourth quarter worth approximately $59,000. Finally, Bruce G. Allen Investments LLC purchased a new stake in shares of Cardinal Health during the fourth quarter worth approximately $66,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $102.83 on Tuesday. The firm’s fifty day simple moving average is $109.58 and its 200-day simple moving average is $104.50. The stock has a market capitalization of $25.01 billion, a price-to-earnings ratio of 40.48, a PEG ratio of 1.04 and a beta of 0.68. Cardinal Health, Inc. has a 12 month low of $77.56 and a 12 month high of $116.04.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, February 1st. The company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.56 by $0.26. The business had revenue of $57.45 billion for the quarter, compared to analysts’ expectations of $57.02 billion. Cardinal Health had a net margin of 0.30% and a negative return on equity of 57.44%. The company’s quarterly revenue was up 11.6% on a year-over-year basis. During the same period in the previous year, the company posted $1.32 EPS. Analysts anticipate that Cardinal Health, Inc. will post 7.28 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were given a $0.5006 dividend. The ex-dividend date of this dividend was Thursday, March 28th. This represents a $2.00 dividend on an annualized basis and a yield of 1.95%. Cardinal Health’s dividend payout ratio (DPR) is 78.74%.

Analyst Upgrades and Downgrades

CAH has been the topic of a number of recent research reports. UBS Group upped their target price on shares of Cardinal Health from $122.00 to $125.00 and gave the stock a “buy” rating in a research note on Monday, February 5th. Barclays started coverage on shares of Cardinal Health in a research note on Wednesday, January 3rd. They issued an “overweight” rating and a $117.00 price target on the stock. Argus upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating in a research note on Friday, February 9th. SVB Leerink started coverage on shares of Cardinal Health in a research note on Monday, February 26th. They issued an “outperform” rating and a $125.00 price target on the stock. Finally, TheStreet lowered shares of Cardinal Health from a “b-” rating to a “c+” rating in a research note on Wednesday, December 27th. One analyst has rated the stock with a sell rating, three have given a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $103.07.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.